06.01.2013 Views

Business Potential for Agricultural Biotechnology - Asian Productivity ...

Business Potential for Agricultural Biotechnology - Asian Productivity ...

Business Potential for Agricultural Biotechnology - Asian Productivity ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Global Status and Trends of Commercialized <strong>Biotechnology</strong> in Crops<br />

brought into agricultural production than any other country in the world, up to 100 million ha or<br />

more, with an ample water supply—the major global constraint to increased crop production.<br />

Brazil also has the third-largest area of maize in the world, after the U.S. and China, with<br />

significant potential <strong>for</strong> both biotech insect-resistant and herbicide-tolerant varieties. Unlike soybean,<br />

which are generally produced on larger farms, the 12 million ha of maize in Brazil is<br />

farmed mainly by small farmers to whom the social benefits of increased income would be very<br />

important and consistent with the government’s top priority of alleviating poverty. Brazil also<br />

has the sixth-largest area of cotton in the world and uses the greatest quantity of cotton insecticides<br />

in Latin America. Adoption of insect-resistant biotech cotton could result in significant advantages<br />

<strong>for</strong> both the small and large farmers who grow cotton, including less exposure to insecticides<br />

and higher net incomes. Using only current proven biotech crops of soybean, maize, and<br />

cotton, already successfully commercialized in other countries, the collective value <strong>for</strong> these<br />

three crops in Brazil could probably be increased by up to USD1 billion per year, with significant<br />

added environmental, health, and social benefits that are particularly important <strong>for</strong> small,<br />

resource-poor farmers who could enhance their income and have less exposure to pesticides.<br />

South Africa<br />

A draft National <strong>Biotechnology</strong> Strategy was completed in 2001 that provided <strong>for</strong> three<br />

centers of excellence funded at USD64 million over three years. These centers provide a framework<br />

<strong>for</strong> a national PlantBio network, with facilities worth USD4 million at the University of<br />

Pretoria, which acts as a hub <strong>for</strong> crop biotechnology, including an in<strong>for</strong>matics and gene technology<br />

center. The most advanced public-sector product is a Bt potato resistant to the tuber moth,<br />

currently being field tested. Other potential new biotech crops from both the private and the<br />

public sectors that are in advanced field tests are stacked Bt/herbicide-tolerant cotton and maize,<br />

sugarcane with modified carbohydrate, and virus-resistant potatoes undergoing tests in greenhouses.<br />

The stacked Bt/herbicide-tolerant cotton is currently under advanced field testing. Despite<br />

a shortage of biotech maize seed, which has constrained adoption rates, 240,000 ha of<br />

yellow maize (24% of the total) and 155,000 ha (10% adoption) of white maize are estimated <strong>for</strong><br />

2004–05, with continued strong growth projected <strong>for</strong> the future. It is notable that Bt white maize<br />

has been rapidly accepted as a food crop, increasing from 6,000 ha in 2001 to 155,000 ha in<br />

2004. The stacked Bt/herbicide-tolerant maize is currently under advanced field testing, and<br />

expedited approval of this product is important so that South Africa can maintain its lead role in<br />

biotech crops. Biotech soybeans were introduced in 2001, and the adoption rate moved rapidly<br />

from 5% in 2001 to an estimated 50% in 2004, with continued strong growth expected <strong>for</strong> 2005<br />

and beyond.<br />

TRENDS AND FUTURE DEVELOPMENTS<br />

The future of crop biotechnology products will depend, to a large extent, on their proven<br />

benefits to the farming community, a regime of acceptable biosafety oversight, and public/consumer<br />

acceptance. Regulatory frameworks <strong>for</strong> biosafety are being developed by many countries<br />

that are signatories to the Cartagena Biosafety Protocol under the Convention on Biological<br />

Diversity, and the methodology <strong>for</strong> safety assessment has also increasingly been improved vis-àvis<br />

its science and acceptance by governments (Thomas and Fuchs, 2002).<br />

Benefits from Biotech Crops<br />

The experience of the first nine years, 1996 to 2004, during which a cumulative total of<br />

over 385 million ha (951 million acres, equivalent to 40% of the total land area of the U.S. or<br />

China) of biotech crops were planted globally in 22 countries, has met the expectations of<br />

millions of large and small farmers in both industrial and developing countries. Biotech crops<br />

are also delivering benefits to consumers and society at large, through more af<strong>for</strong>dable food,<br />

– 43 –

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!